Product Strategy

Strategic Product Portfolio Architecture Our product development strategy is organized around three distinct categories, each serving a specific role in building market presence and addressing unmet veterinary needs across Southeast Asia. This structured approach allows us to balance quick wins with strategic differentiation. Current Product Gaps

First-line antibiotic products with proven formulations, low development risk, fast-to-market potential, and competitive pricing advantages through local manufacturing. My heading is awesome

Modified dermatology solutions designed specifically for tropical climate conditions, high clinic demand, and premium positioning in the fastest-growing therapeutic category. Strategic Innovation

Non-antibiotic products addressing unmet needs in chronic conditions, medium development risk balanced by significant market differentiation and higher margin potential.

Our Therapeutic Focus Areas

Dermatological Health

Addressing the most common clinical presentation in Southeast Asian companion animal practice. Humid tropical climates create ideal conditions for bacterial and fungal skin conditions.

Gut Health Solutions

Supporting digestive wellness and microbiome balance with products designed for regional feeding practices and common gastrointestinal challenges in SEA companion animals.

Recovery Support

Products that aid post-treatment and post-viral recuperation, helping pets return to full health after illness or medical procedures with science-backed nutritional support.

Therapeutic Specialty

Focused solutions for unmet needs identified by regional veterinarians, particularly in areas where imported products fail to deliver adequate efficacy or accessibility.

Oclacitinib – Non-Antibiotic Dermatology Innovation Apoquel-Type Immunomodulator for Chronic Pruritus

Strategic Positioning

This is not an antibiotic – it’s a targeted immunomodulator that addresses the underlying immune dysfunction driving chronic dermatitis and allergic pruritus. Represents a fundamentally different treatment approach.

Market Opportunity

High unmet need in chronic itch and allergic dermatitis cases where antibiotic therapy is inappropriate. Current imported products are expensive and supply can be inconsistent, creating opportunity for local manufacturing.

Development Complexity

Medium development risk due to specialized API handling, formulation optimization requirements, and need for tropical climate stability data. Requires comprehensive feasibility assessment before commitment.

Technical Development Requirements API sourcing from qualified manufacturers with veterinary pharmaceutical experience
Potency and handling protocols for immunomodulator compounds
Extensive stability testing under ASEAN climate conditions
Formulation optimization for moisture protection and shelf life

Regulatory & Commercial Pathway Intellectual property landscape assessment for SEA markets
Regulatory pathway strategy across Thailand, Vietnam, Malaysia
Competitive positioning against imported reference product
Premium pricing strategy balanced with accessibility goals